Cargando…

Optimizing subjective wellbeing with amisulpride in first episode schizophrenia or related disorders

BACKGROUND: Subjective response (SR) to antipsychotic medication is relevant for quality of life, adherence and recovery. Here, we evaluate (1) the extent of variation in SR in patients using a single antipsychotic; (2) the association between subjective and symptomatic response; and (3) predictors...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Haan, Lieuwe, van Tricht, Mirjam, van Dijk, Floor, Arango, Celso, Díaz-Caneja, Covadonga M., Bobes, Julio, García-Álvarez, Leticia, Leucht, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520587/ https://www.ncbi.nlm.nih.gov/pubmed/36520136 http://dx.doi.org/10.1017/S0033291722003142

Ejemplares similares

T117. PROMINENT AND PERSISTENT AUTISTIC TRAITS ARE ASSOCIATED WITH EARLY NON-REMISSION IN FIRST-EPISODE SCHIZOPHRENIA
por: Pina-Camacho, Laura, et al.
Publicado: (2020)

O11.3. A LONGITUDINAL ANALYSIS OF THE EFFECTS OF NEUROTICISM AND EXTRAVERSION ON SUBJECTIVE WELL-BEING IN PATIENTS WITH SCHIZOPHRENIA
por: van Dijk, Floor, et al.
Publicado: (2018)

Oxidative Stress and Inflammation in Early Onset First Episode Psychosis: A Systematic Review and Meta-Analysis
por: Fraguas, David, et al.
Publicado: (2017)

Scalability of the Positive and Negative Syndrome Scale in first‐episode schizophrenia assessed by Rasch models
por: Baandrup, Lone, et al.
Publicado: (2022)

Early interventions in risk groups for schizophrenia: what are we waiting for?
por: Sommer, Iris E, et al.
Publicado: (2016)

T24. CHANGES IN TELOMERE LENGTH IN YOUNG PEOPLE WITH FIRST EPISODE PSYCHOSIS: A 12-MONTHS FOLLOW-UP STUDY
por: Ayora, Mirian, et al.
Publicado: (2020)

Rechallenge with Amisulpride in a Patient with Schizophrenia following a Manic Episode during Previous Therapy
por: Hu, Li-Yu, et al.
Publicado: (2022)

F19. TELOMERE SHORTENING IN YOUNG PEOPLE WITH FIRST EPISODE PSYCHOSIS: A 12-MONTH FOLLOW-UP STUDY
por: Fraguas, David, et al.
Publicado: (2018)

T25. THE RELATIONSHIP BETWEEN AGE AT FIRST-EPISODE AND LONGITUDINAL CORTICAL CHANGES IN FIRST-EPISODE PSYCHOSIS: A TWO-YEAR LONGITUDINAL STUDY IN AN ADOLESCENT AND ADULT-ONSET COHORT
por: Santonja, Javier, et al.
Publicado: (2020)

Update on the management of symptoms in schizophrenia: focus on amisulpride
por: Mortimer, Ann M
Publicado: (2009)

31. OPTIMISE-ING THE TREATMENT OF FIRST-EPISODE SCHIZOPHRENIA
por: Arango, Celso
Publicado: (2018)

Phenotypic factors associated with amisulpride‐induced weight gain in first‐episode psychosis patients (from the OPTiMiSE cohort)
por: Pandit, R., et al.
Publicado: (2019)

Reduced Context Effects on Retrieval in First-Episode Schizophrenia
por: Talamini, Lucia M., et al.
Publicado: (2010)

PM391. THE USE OF AMISULPRIDE IN TREATMENT OF PATIENTS WITH RESIDUAL SCHIZOPHRENIA
por: Janjic, Vladimir, et al.
Publicado: (2016)

A cost-utility analysis of Amisulpride and Paliperidone in the treatment of Schizophrenia
por: Abdall-Razak, Ali, et al.
Publicado: (2019)

Hyperprolactinaemia with amisulpride
por: Raj, Rajnish, et al.
Publicado: (2008)

Negative symptoms in First-Episode Schizophrenia related to morphometric alterations in orbitofrontal and superior temporal cortex: the OPTiMiSE study
por: Demjaha, Arsime, et al.
Publicado: (2023)

Persistent hiccup as an adverse effect of amisulpride in a patient with first episode of psychosis.
por: Retsou, I., et al.
Publicado: (2023)

Specificity of facial emotion recognition impairments in patients with multi-episode schizophrenia
por: Barkhof, Emile, et al.
Publicado: (2015)

Burying Our Heads in the Sand: The Neglected Importance of Reporting Inter-Rater Reliability in Antipsychotic Medication Trials
por: Berendsen, Steven, et al.
Publicado: (2020)

Socioeconomic status and severe mental disorders: a bidirectional multivariable Mendelian randomisation study
por: Andreu-Bernabeu, Álvaro, et al.
Publicado: (2023)

M41. TRAJECTORIES AND PREDICTORS OF OUTCOME IN SCHIZOPHRENIA: THE BENEFICIAL ROLE OF AMISULPRIDE
por: Drosos, Petros, et al.
Publicado: (2020)

S95. DIFFERENCES IN LIFETIME PATTERNS OF PSYCHOSTIMULANTS AND THEIR IMPACT ON THE PROPORTION OF PATIENTS WITH FIRST-EPISODE PSYCHOSIS ATTRIBUTABLE TO PSYCHOSTIMULANTS USE ACROSS EUROPE
por: Duran-Cutilla, Manuel, et al.
Publicado: (2020)

Polygenic contribution to the relationship of loneliness and social isolation with schizophrenia
por: Andreu-Bernabeu, Álvaro, et al.
Publicado: (2022)

Differential Effects of Aripiprazole and Amisulpride on Negative and Cognitive Symptoms in Patients With First-Episode Psychoses
por: Nielsen, Mette Ødegaard, et al.
Publicado: (2022)

Amisulpride induced mania
por: Aggarwal, Ashish, et al.
Publicado: (2010)

The bumpy road to achieve reliability of clinical profile characteristics in psychosis and related disorders
por: Berendsen, Steven, et al.
Publicado: (2020)

Recent natural selection conferred protection against schizophrenia by non-antagonistic pleiotropy
por: González-Peñas, Javier, et al.
Publicado: (2023)

Pharmacological Treatment of Early-Onset Schizophrenia: A Critical Review, Evidence-Based Clinical Guidance and Unmet Needs
por: Lopez-Morinigo, Javier-David, et al.
Publicado: (2022)

Repetitive transcranial magnetic stimulation combined with olanzapine and amisulpride for treatment-refractory schizophrenia
por: Liu, Jin-Ling, et al.
Publicado: (2023)

Identification and management of cardiometabolic risk in subjects with schizophrenia spectrum disorders: A Delphi expert consensus study
por: Galderisi, Silvana, et al.
Publicado: (2021)

The association between gene variants and longitudinal structural brain changes in psychosis: a systematic review of longitudinal neuroimaging genetics studies
por: Harari, Julia H., et al.
Publicado: (2017)

Amisulpride Reexposure and Tardive Dyskinesia
por: Sidana, Ajeet
Publicado: (2018)

Sustained specialized and family treatment in first-episode schizophrenia or related disorders: a 5-year randomized controlled trial
por: de Haan, Lieuwe, et al.
Publicado: (2023)

Population pharmacokinetics of Amisulpride in Chinese patients with schizophrenia with external validation: the impact of renal function
por: Li, Anning, et al.
Publicado: (2023)

Association of cognitive performance with clinical staging in schizophrenia spectrum disorders: a prospective 6-year follow-up study
por: Berendsen, S., et al.
Publicado: (2021)

Predictors of outcome in early-onset psychosis: a systematic review
por: Díaz-Caneja, Covadonga M, et al.
Publicado: (2015)

The effects of amisulpride on five dimensions of psychopathology in patients with schizophrenia: a prospective open- label study
por: Herrera-Estrella, Miguel, et al.
Publicado: (2005)

Effect of Peony-Glycyrrhiza Decoction on Amisulpride-Induced Hyperprolactinemia in Women with Schizophrenia: A Preliminary Study
por: Yang, Ping, et al.
Publicado: (2017)

Amisulpride augmentation of clozapine for treatment-refractory schizophrenia: a double-blind, placebo-controlled trial
por: Barnes, Thomas R.E., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3ldbsosvgripmi5derdfhiocdt